Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Finally! Easy to parse data!

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon May 03, 2022 9:05am

121 Views

Post# 34650513

RE:RE:RE:Finally! Easy to parse data!

Agree. Seems like 360 days and no recurrence, you are good to go. So for our purposes I would consider any that have reached 360 as being almost countable as a permanent cure. Makes sense that if you have had 1-2 treatments and nothing has shown up on cytology OR cystocscope by 1 yrs, that it is gone. I know that won't be the FDA's thinking but it is nice info for us to keep in our minds.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments